Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

In Silico Non Interventional Secondary Use of Data Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

Next Previous
Search
Trial Profile

In Silico Non Interventional Secondary Use of Data Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Dec 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Evolocumab (Primary) ; Ezetimibe (Primary) ; Inclisiran (Primary)
  • Indications Cardiovascular disorders
  • Focus Therapeutic Use
  • Acronyms SIRIUS
  • Sponsors Novartis Pharmaceuticals

    • Most Recent Events

    • 18 Nov 2024 Results of an analysis assessing potential efficacy of inclisiran on CV outcomes in virtual patients with or without prior ischemic stroke over 5 years presented at the American Heart Association Scientific Sessions 2024
    • 18 Nov 2024 Results predicting the effect of inclisiran compared to ezetimibe or evolocumab on MACE in participants with atherosclerotic cardiovascular disease presented at the American Heart Association Scientific Sessions 2024.
    • 07 May 2024 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top